Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19)

Impact of vitamin D deficiency on prognosis of patients novel coronavirus pneumonia (COVID-19)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000029732

Enrollment

Unknown

Registered

2020-02-10

Start date

2020-02-10

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Vitamin D deficiency group:N/A

Vitamin D normal group:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years. 2. Patients who meet the diagnostic criteria of suspected cases of pneumonia caused by novel coronavirus infection.

Exclusion criteria

Exclusion criteria: 1. Patients without any clinical and chest imaging findings; 2. Supplementation with vitamin D or calcium within one week before admission 3. Patients with severe failure with chronic organ dysfunction; 4. Malignant tumors; diseases of the immune system; radiation and chemotherapy. 5. Pregnancy: The pregnancy test is positive for women of childbearing age; the breastfeeding women have not stopped breastfeeding.

Design outcomes

Primary

Measure	Time frame
ROX index;	—

Secondary

Measure	Time frame
length of stay;the rate of transfer to critical ill patients;length of stay in ICU;28-day mortality;complication;	—

Countries

China

Contacts

Public ContactJun Guo

West China Hospital, Sichuan University

guojun@wchscu.cn+86 15388178461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026